Angela Bellini

发表

Clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction

E. Barillot, O. Delattre, J. Maris, 2016, bioRxiv.

Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma

O. Delattre, V. Bernard, V. Combaret, 2017, Clinical Cancer Research.

Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse

S. Cohn, G. Schleiermacher, N. Bown, 2016, Oncotarget.

Fission Yeast Rad52 Phosphorylation Restrains Error Prone Recombination Pathways

E. Sage, S. Francesconi, Angela Bellini, 2014, PloS one.

Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma

D. Surdez, O. Delattre, H. Brisse, 2022, Journal for ImmunoTherapy of Cancer.

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Gudrun Schleiermacher, Jan Koster, Javed Khan, 2015, Nature Genetics.

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

P. Gestraud, D. Surdez, O. Delattre, 2022, bioRxiv.

Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)

O. Delattre, A. Vicha, P. Ambros, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interplay between intrinsic reprogramming potential and microenvironment controls neuroblastoma cell plasticity and identity

D. Surdez, O. Delattre, H. Brisse, 2021, bioRxiv.

ALK mutation dynamics and clonal evolution in a neuroblastoma model exhibiting two ALK mutations

O. Delattre, E. Daudigeos-Dubus, V. Combaret, 2019, Oncotarget.

Detection of tumor ALK status in neuroblastoma patients using peripheral blood

J. Blay, V. Bernard, V. Combaret, 2015, Cancer medicine.

Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis

O. Delattre, V. Bernard, V. Combaret, 2015, Clinical Cancer Research.

QuantumClone: clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction

Emmanuel Barillot, Gudrun Schleiermacher, John M. Maris, 2018, Bioinform..

Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma

Gudrun Schleiermacher, Olivier Delattre, David Gentien, 2016, Clinical Cancer Research.

Stress Activated Protein Kinase Pathway Modulates Homologous Recombination in Fission Yeast

E. Sage, S. Francesconi, S. Lambert, 2012, PloS one.

Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma

O. Delattre, V. Bernard, V. Combaret, 2019, International journal of cancer.

Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma

D. Surdez, H. Brisse, B. Geoerger, 2023, Nature communications.

Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma

T. Hocking, S. Boyault, O. Delattre, 2016, Clinical Cancer Research.

Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis

O. Delattre, V. Bernard, V. Combaret, 2015, Clinical Cancer Research.